Cognitive enhancers for the treatment of ADHD

Pharmacol Biochem Behav. 2011 Aug;99(2):262-74. doi: 10.1016/j.pbb.2011.05.002. Epub 2011 May 10.

Abstract

Attention-deficit hyperactivity disorder (ADHD) is associated with multiple cognition-related phenotypic features in both children and adults. This review aims to clarify the role of cognition in ADHD and how prevailing treatments, which are often highly effective at reducing the clinical symptoms of the disorder, fare in modulating ADHD-related cognitive processes. First, we consider how the broad construct of cognition can be conceptualized in the context of ADHD. Second, we review the available evidence for how a range of both pharmacological and non-pharmacological interventions have fared with respect to enhancing cognition in individuals affected by this pervasive disorder. Findings from the literature suggest that the effects across a broad range of pharmacological and non-pharmacological interventions on the characteristic symptoms of ADHD can be distinguished from their effects on cognitive impairments. As such the direct clinical relevance of cognition enhancing effects of different interventions is somewhat limited. Recommendations for future research are discussed, including the identification of cognition-related endophenotypes, the refinement of the ADHD clinical phenotype, and studying the difference between acute and chronic treatment regimens.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Adult
  • Amphetamine / therapeutic use
  • Atomoxetine Hydrochloride
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Attention Deficit Disorder with Hyperactivity / psychology
  • Attention Deficit Disorder with Hyperactivity / therapy
  • Child
  • Cholinergic Agents / therapeutic use
  • Clonidine / therapeutic use
  • Cognition / drug effects
  • Executive Function / drug effects
  • Guanfacine / therapeutic use
  • Humans
  • Intelligence / drug effects
  • Methylphenidate / therapeutic use
  • Nootropic Agents / therapeutic use*
  • Propylamines / therapeutic use
  • Reward
  • Social Behavior

Substances

  • Cholinergic Agents
  • Nootropic Agents
  • Propylamines
  • Methylphenidate
  • Guanfacine
  • Atomoxetine Hydrochloride
  • Amphetamine
  • Clonidine